Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1998-8-25
|
pubmed:abstractText |
Gene therapy, in the future, may offer new strategies to treat various malignancies in lung cancer. Several phase I trials have demonstrated the safety of these approaches. The limitation of current gene transfer techniques include transient gene expression, locoregional delivery, and the ability to target tumor tissue in a safe manner.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1055-3207
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
603-16
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading | |
pubmed:year |
1998
|
pubmed:articleTitle |
Gene therapy for human lung cancers.
|
pubmed:affiliation |
Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
|
pubmed:publicationType |
Journal Article,
Review
|